Attenuating Renal Interstitial Fibrosis by Shenqi Pill via  Reducing Inflammation Response Regulated by NF-κB Pathway In Vitro and In Vivo

Conclusion. SQP has a reno-protective effect against RIF in vivo and in vitro, and the effect is partly linked to nuclear factor-kappa B (NF-κB) pathway related inflammatory response, which indicates that SQP may be a candidate drug for RIF. DOI: 10.52547/ijkd.7546.PMID:38660700 | DOI:10.5254/kv5ap920
Source: Iranian Journal of Kidney Diseases - Category: Urology & Nephrology Authors: Source Type: research